Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0360-3016(99)00183-2PMID 10487552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Innovations in Three-Dimensional Treatment Planning and Quality Assurance

  1998cited by this paper
• The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy.

  1998cited by this paper
• Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation.

  1998cited by this paper
• Computer-controlled delivery of 3D conformal radiation treatments.

  1998cited by this paper
• Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.

  1998cited by this paper
• Three-dimensional treatment planning and conformal dose delivery--a physicist's perspective.

  1998cited by this paper
• Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.

  1998cited by this paper
• Advances in three-dimensional treatment planning and conformal dose delivery.

  1997cited by this paper
• Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer.

  1997cited by this paper
• Advances in three-dimensional treatment planning and conformal dose delivery.

  1997cited by this paper
• Physical and biological predictors of changes in whole-lung function following thoracic irradiation.

  1997cited by this paper
• Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.

  1997cited by this paper
• Plasma transforming growth factor β1 as a predictor of radiation pneumonitis

  1997cited by this paper
• Predicting radiation response.

  1997cited by this paper
• Evaluation of an objective plan-evaluation model in the three dimensional treatment of nonsmall cell lung cancer.

  1996cited by this paper
• 3-D conformal radiotherapy for lung cancer. The Washington University experience.

  1996cited by this paper
• Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.

  1995cited by this paper
• Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.

  1994cited by this paper
• The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol

  1993cited by this paper
• The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol.

  1993cited by this paper
• Advances in 3-dimensional radiation treatment planning systems: room-view display with real time interactivity.

  1993cited by this paper
• Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

  1991cited by this paper
• Tolerance of normal tissue to therapeutic irradiation.

  1991cited by this paper
• Fitting of normal tissue tolerance data to an analytic function.

  1991cited by this paper
• Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

  1989cited by this paper
• IMEX: A Tool For Image Display And Contour Management In A Windowing Environment

  1989cited by this paper
• BMDP statistical software

  1983cited by this paper
• Dose rate relationships in brachytherapy: An in-vivo evaluation

  1977cited by this paper

• Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans

  2026cites this paper
• Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology.

  2026cites this paper
• Dosimetric comparison of Monte Carlo, Acuros XB, and anisotropic analytical algorithm for lung cancer plans on halcyon accelerators

  2025cites this paper
• V15(Gy) as a predictor of asymptomatic radiation pneumonitis in patients with lung cancer: A retrospective dosimetric analysis

  2025cites this paper
• Anatomical Parameter-driven Volumetric Modulated Arc Therapy Optimization in Left-sided Breast Cancer: A Machine Learning Framework for Lung Dose Prediction

  2025cites this paper
• Dosimetric Evaluation of Tangential Arc and Jaw Tracking Techniques in Volumetric Modulated Arc Therapy for Synchronous Bilateral Breast Cancer

  2025cites this paper
• Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation.

  2025cites this paper
• Preclinical characterisation of changes in cardiac function and circulating biomarkers following differential irradiation of thoracic volumes

  2025cites this paper
• D3Net: A Distribution-Driven Deep Network for Radiotherapy Dose Prediction

  2025cites this paper
• FDDM: Frequency-Decomposed Diffusion Model for Dose Prediction in Radiotherapy

  2025cites this paper
• Impact of Smoking and Lung Capacity on Disease Recovery: A Machine Learning Perspective

  2025cites this paper
• Association Between Lung Volume Reduction and Symptomatic Radiation Pneumonitis in Lung Cancer Patients Undergoing Definitive Concurrent Chemoradiotherapy.

  2025cites this paper
• The Influencing Factors of Radiation Pneumonia in Lung Cancer Patients Undergoing Radiotherapy

  2025cites this paper
• Comparative analysis of VMAT plans on Halcyon and infinity for lung cancer radiotherapy

  2025cites this paper
• Biodistribution of Macroaggregated Albumin (MAA) After Tumor Model Development and Characterization in a Porcine Lung Cancer Model.

  2025cites this paper
• Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging.

  2025cites this paper
• Pneumonitis after chemoradiation followed by durvalumab for locally advanced lung cancer, predictors and effect on survival.

  2025cites this paper
• Multiomic based Bayesian network toxicity modeling for simultaneous prediction of multiple toxicity outcomes in NSCLC.

  2025cites this paper
• A retrospective study of automatic progressive optimization for lung cancer radiotherapy plans on the Halcyon and RayStation systems

  2025cites this paper
• Comparative dosimetric evaluation of hybrid volumetric modulated arc therapy techniques for oesophageal cancer: a treatment planning study

  2025cites this paper
• Dosimetric analysis and acute toxicity in cranio-spinal irradiation using helical tomotherapy: Experience from a tertiary cancer center

  2025cites this paper
• Quantifying changes in ventilation for photon- and proton-treated patients according to dose and pneumonitis development

  2025cites this paper
• Radiotherapy for primary lung cancer: 2025 update.

  2025cites this paper
• Thymus Composition Predicts Pneumonitis Risk in Lung Cancer Therapy

  2025cites this paper
• Multi-region Multiomic Random Forest Toxicity Modeling of Radiation Pneumonitis.

  2024cites this paper
• Application of dose-gradient function in reducing radiation induced lung injury in breast cancer radiotherapy

  2024cites this paper
• Triplet-Constraint Transformer with Multi-Scale Refinement for Dose Prediction in Radiotherapy

  2024cites this paper
• Gastroscopic observation and dose-volume histogram parameter study on gastrointestinal mucous injury for pancreatic cancer treated with TOMO

  2024cites this paper
• A dosimetric comparative study of carbon-ion radiotherapy versus x-ray volumetric modulated arc therapy for stage III non-small-cell lung cancer

  2024cites this paper
• Bronchiolitis obliterans organizing pneumonia (BOOP) after breast radiation therapy.

  2024cites this paper
• Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys

  2024cites this paper
• Deep Learning-based Lung dose Prediction Using Chest X-ray Images in Non-small Cell Lung Cancer Radiotherapy

  2024cites this paper
• Real-world Outcomes of Durvalumab Consolidation in Elderly Patients With Unresectable NSCLC Following CCRT With Daily Low-dose Carboplatin

  2024cites this paper
• Enhancing the prediction of symptomatic radiation pneumonitis for locally advanced non-small-cell lung cancer by combining 3D deep learning-derived imaging features with dose–volume metrics: a two-center study

  2024cites this paper
• Evaluation of Malignant Lung Tumor Motion Comparing to Fix Point during Different Respiratory Phases on Four-Dimensional Computed Tomography.

  2024cites this paper
• Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

  2024cites this paper
• Defining a parameter to select the best radiotherapy technique in patients with right breast cancer after conservative surgery: Evaluation of high doses and risk of radio-induced second tumors to the ipsilateral lung.

  2024cites this paper
• DSANet: Dual-path segmentation-guided attention network for radiotherapy dose prediction from CT images only

  2024cites this paper
• Proton therapy for breast cancer: Reducing toxicity

  2024cites this paper
• Assessment of Organ-at-risk Sparing in Esophageal Cancer: A Comparative Dosimetric Evaluation of Hybrid, Noncoplanar, and Coplanar RapidArc Plans

  2024cites this paper
• Impact of Normal Lung Volume Choices on Radiation Pneumonitis Risk Prediction in Locally Non-small Cell Lung Cancer Radiation Therapy

  2024cites this paper
• Robust localization of poorly visible tumor in fiducial free stereotactic body radiation therapy.

  2024cites this paper
• Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts

  2024cites this paper
• Radiation Induced Skin Fibrosis (RISF): Opportunity for Angiotensin II-Dependent Intervention

  2024cites this paper
• Proton Beam Therapy for Unresectable Mediastinal and Pericardial Spindle Cell Sarcoma: A Case Report

  2023cites this paper
• Diffusion-Based Radiotherapy Dose Prediction Guided by Inter-Slice Aware Structure Encoding

  2023cites this paper
• A comparison of the incidence of ≥ grade 2 radiation pneumonitis between intensity-modulated radiotherapy and three-dimensional conformal radiotherapy in patients with unresectable non-small cell lung cancer treated with durvalumab after concurrent chemoradiotherapy.

  2023cites this paper
• Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy

  2023cites this paper
• Exploration of molecular mechanism underlying protective effect of astragaloside IV against radiation-induced lung injury by suppressing ferroptosis.

  2023cites this paper
• DiffDP: Radiotherapy Dose Prediction via a Diffusion Model

  2023influential citation
• Unsupervised Domain Adaptive Dose Prediction via Cross-Attention Transformer and Target-Specific Knowledge Preservation

  2023cites this paper
• Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial.

  2023cites this paper
• Application research on reducing radiation-induced lung injury with a trigger operator based on overlap volume histogram (OVH) in breast cancer postoperative radiotherapy

  2023cites this paper
• Biomedical advances and future prospects of high-precision three-dimensional radiotherapy and four-dimensional radiotherapy

  2023cites this paper
• Consideration of lung dose changes when establishing lung cancer treatment plans according to tumor changes

  2023cites this paper
• A Transformer-Embedded Multi-Task Model for Dose Distribution Prediction

  2023cites this paper
• Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer

  2023cites this paper
• Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy

  2023cites this paper
• External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy.

  2023cites this paper
• Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer

  2023cites this paper
• Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.

  2023cites this paper
• Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm

  2023cites this paper
• Early Detection of Radiation Pneumonitis on Cone-Beam CT Images During a Course of Radiotherapy: A Case Series Report

  2023cites this paper
• Demystifying the results of RTOG 0617: Identification of dose sensitive cardiac sub-regions associated with overall survival.

  2023cites this paper
• Locally advanced non-small cell lung cancer: current issues and recent trends

  2023cites this paper
• Assessment of Treatment Plan Quality between Flattening Filter and Flattening Filter Free Photon Beam for Carcinoma of the Esophagus with IMRT Technique

  2023cites this paper
• Clinical management of stage III non‐small cell lung cancer in India: An expert consensus statement

  2023cites this paper
• Multi-level progressive transfer learning for cervical cancer dose prediction

  2023cites this paper
• Different Intensity-Modulated Radiotherapy Plans for Breast Cancer: A Dosimetric Comparison

  2022cites this paper
• Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters

  2022cites this paper
• VMAT-Based Planning Allows Sparing of a Spatial Dose Pattern Associated with Radiation Pneumonitis in Patients Treated with Radiotherapy for a Locally Advanced Lung Cancer

  2022cites this paper
• Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer

  2022cites this paper
• Feasibility of Differential Dose—Volume Histogram Features in Multivariate Prediction Model for Radiation Pneumonitis Occurrence

  2022cites this paper
• Association between tumor morphology and dosimetric parameters of organs at risk after intensity‐modulated radiotherapy in esophagus cancer

  2022cites this paper
• Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy

  2022influential citation
• A Dosimetric Study Comparing 3D-CRT vs. IMRT vs. VMAT in Left-Sided Breast Cancer Patients After Mastectomy at a Tertiary Care Centre in Eastern India

  2022cites this paper
• Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars

  2022cites this paper
• Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer

  2022cites this paper
• Postmastectomy chest wall radiation of left-sided carcinoma breast - a dosimetric comparison between electrons and photons

  2022cites this paper
• Radiation pneumonitis prediction model with integrating multiple dose-function features on 4DCT ventilation images.

  2022cites this paper
• Precision radiotherapy by SPECT lung functional imaging in NSCLC

  2022cites this paper
• A pictorial essay on radiological changes after stereotactic body radiation therapy for lung tumors

  2022cites this paper
• Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab.

  2022cites this paper
• Can bronchoscopically implanted anchored electromagnetic transponders be used to monitor tumor position and lung inflation during deep inspiration breath-hold lung radiotherapy?

  2022cites this paper
• Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

  2022cites this paper
• Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

  2022cites this paper
• Computational dose visualization & comparison in total skin electron treatment suggests superior coverage by the rotational versus the Stanford technique.

  2022cites this paper
• Radiation Oncology: Future Vision for Quality Assurance and Data Management in Clinical Trials and Translational Science

  2022cites this paper
• analysis of coplanar and non-coplanar intensity-modulated radiotherapy planning for esophageal cancer

  2022cites this paper
• Dosimetric Evaluation of Various Radiation Therapy Treatment Techniques for Carcinoma Esophagus: A Treatment Planning Study

  2022cites this paper
• Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation

  2022cites this paper
• Integrating 18F‐FDG PET/CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot study

  2022cites this paper
• Divided target optimization with volumetric modulated arc therapy planning to improve target coverage and homogeneity in lung radiation therapy.

  2022cites this paper
• Anatomy-based prediction method for determining ipsilateral lung doses in postoperative breast radiation therapy assisted by diagnostic computed tomography images

  2022cites this paper
• 18F-FDG PET/CT as a Potential Predictor of Lung In ammation After Arc-Based Radiotherapy for Esophageal Cancer: A Pilot Study

  2021cites this paper
• Incorporating Isodose Lines and Gradient Information via Multi-task Learning for Dose Prediction in Radiotherapy

  2021cites this paper
• Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).

  2021cites this paper
• Survivorship Programs for the Cancer Survivor: Next steps for the Modern Cancer Patient

  2021cites this paper
• Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.

  2021cites this paper
• Radiation Oncology: Modern Review of Treatment Toxicity

  2021cites this paper